Summary:
- RSI is at a high level of 72. A high level of RSI indicates the stock is overbought.
- MACD is crossing MACD signal line at 0.6. MACD crossing signal line is bullish signal.
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.
* Enables Itamar to leverage Spry’s existing FDA-cleared technology to bring to market the first device for continuous remote patient monitoring (RPM) of sleep apnea * Adds the capability to monitor the longer-term accumulated disease burden of sleep apnea to complement the single night diagnostics commonly used today, including the Company’s existing WatchPAT™ device * Paves the way for an end-to-end digital care pathway that can further expand Itamar’s presence in obstructive sleep a...
\- 2020 Fourth Quarter Revenues Expected to Increase More Than 28% to $12.5-$12.8 million - \- 2020 Fiscal Year Revenues Expected to Increase Approximately 31% to $40.8-$41.1 million - CAESAREA, Israel, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today reported preliminary unaudited revenue results for the fourth q...
Positive Coverage Policy from Health Care Service Corporation (HCSC) Covers Blue Cross Blue Shield Members in Illinois, Montana, New Mexico, Oklahoma and TexasCAESAREA, Israel, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced that Health Care Service Corporation (HCSC), the largest customer-owned health insur...
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious towards the current bull run since March and hedging or reducing many of their long positions. Some fund managers are betting on Dow hitting […]
WatchPAT™ to effectively maintain current reimbursement levels despite broader reduction in conversion rates Table 1 New reimbursement fees for Home Sleep Apnea TestingCAESAREA, Israel, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today commented on the recent release of the 2021 Physician Fee Schedule from the U.S. Cent...
Results Further Support Use of WatchPAT for Home-Based Sleep Apnea Testing as an Effective Alternative to In-Lab PSG TestingCAESAREA, Israel, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company leading the integration of sleep apnea management into the cardiac patient care pathway, today announced the publication of a new study titled, ‘Watch-PAT is Useful in the Diagnosis of Sleep Apnea in Patients with Atrial Fibril...